- Home
- SACH vs LSB Comparison
SACH vs LSB Comparison
Compare SACH & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SACH
- LSB
- Stock Information
- Founded
- SACH 2010
- LSB 2002
- Country
- SACH United States
- LSB China
- Employees
- SACH N/A
- LSB N/A
- Industry
- SACH Real Estate Investment Trusts
- LSB
- Sector
- SACH Real Estate
- LSB
- Exchange
- SACH Nasdaq
- LSB NYSE
- Market Cap
- SACH 50.7M
- LSB 53.6M
- IPO Year
- SACH 2017
- LSB N/A
- Fundamental
- Price
- SACH $1.09
- LSB $2.23
- Analyst Decision
- SACH Buy
- LSB
- Analyst Count
- SACH 2
- LSB 0
- Target Price
- SACH $2.25
- LSB N/A
- AVG Volume (30 Days)
- SACH 395.1K
- LSB 7.4K
- Earning Date
- SACH 03-31-2025
- LSB 12-19-2024
- Dividend Yield
- SACH 22.02%
- LSB N/A
- EPS Growth
- SACH N/A
- LSB N/A
- EPS
- SACH N/A
- LSB N/A
- Revenue
- SACH $10,951,064.00
- LSB $79,415,311.00
- Revenue This Year
- SACH N/A
- LSB $39.33
- Revenue Next Year
- SACH N/A
- LSB $75.61
- P/E Ratio
- SACH N/A
- LSB N/A
- Revenue Growth
- SACH N/A
- LSB N/A
- 52 Week Low
- SACH $1.00
- LSB $1.88
- 52 Week High
- SACH $4.64
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- SACH 44.17
- LSB 40.56
- Support Level
- SACH $1.05
- LSB $2.10
- Resistance Level
- SACH $1.15
- LSB $2.49
- Average True Range (ATR)
- SACH 0.06
- LSB 0.22
- MACD
- SACH 0.01
- LSB 0.00
- Stochastic Oscillator
- SACH 45.00
- LSB 16.35
About SACH Sachem Capital Corp.
Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.